Abstract |
Amyloid diseases like Alzheimer's disease and familial amyloidosis of Finnish type (FAF) stem from endoproteolytic cleavage of a precursor protein to generate amyloidogenic peptides that accumulate as amyloid deposits in a tissue-specific manner. FAF patients deposit both 8 and 5 kDa peptides derived from mutant (D187Y/N) plasma gelsolin in the extracellular matrix (ECM). The first of two aberrant sequential proteolytic events is executed by furin to yield a 68 kDa (C68) secreted fragment. We now identify the metalloprotease MT1-matrix metalloprotease ( MMP), an integral membrane protein active in the ECM, as a protease that processes C68 to the amyloidogenic peptides. We further demonstrate that ECM components are capable of accelerating gelsolin amyloidogenesis. Proteolysis by MT1-MMP-like proteases proximal to the unique chemical environment of the ECM offers an explanation for the tissue-specific deposition observed in FAF and provides critical insight into new therapeutic strategies.
|
Authors | Lesley J Page, Ji Young Suk, Mary E Huff, Hee-Jong Lim, John Venable, John Yates, Jeffery W Kelly, William E Balch |
Journal | The EMBO journal
(EMBO J)
Vol. 24
Issue 23
Pg. 4124-32
(Dec 07 2005)
ISSN: 0261-4189 [Print] England |
PMID | 16281052
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Amyloid
- Gelsolin
- Mmp14 protein, mouse
- Peptide Fragments
- Matrix Metalloproteinases, Membrane-Associated
- Metalloendopeptidases
- Matrix Metalloproteinase 14
|
Topics |
- Amyloid
(biosynthesis)
- Animals
- Cell Line
- Cell Line, Tumor
- Extracellular Matrix
(physiology)
- Gelsolin
(metabolism)
- Humans
- Hydrolysis
- Matrix Metalloproteinase 14
- Matrix Metalloproteinases, Membrane-Associated
- Metalloendopeptidases
(physiology)
- Mice
- Peptide Fragments
(biosynthesis)
|